Method of treating cancer associated with a RAS mutation Grant US-11918574-B2 United States of America 05 Mar 2024
METHODS AND COMPOSITIONS FOR TREATING IRON DISORDERS Application EP-4045046-A4 European Patent Office 10 Jan 2024
Compositions containing tucaresol or its analogs Grant US-11857522-B2 United States of America 02 Jan 2024
Composition and method for reducing thrombocytopenia Grant US-11786523-B2 United States of America 17 Oct 2023
Tubulin binding compounds and therapeutic use thereof Grant US-11633393-B2 United States of America 25 Apr 2023
Polycrystalline form of dehydrophenylahistin-like compound, and manufacturing and… Grant US-11608325-B2 United States of America 21 Mar 2023
Polycrystalline form of dehydrophenylahistin-like compound, and manufacturing and… Grant US-11578057-B2 United States of America 14 Feb 2023
Method of reducing chemotherapy-induced neutropenia Grant US-11400086-B2 United States of America 02 Aug 2022
Composition and method for reducing neutropenia Grant US-11229642-B2 United States of America 25 Jan 2022
Method of treating cancer associated with a RAS mutation Grant US-11045467-B2 United States of America 29 Jun 2021
Compositions containing tucaresol or its analogs Grant US-10912748-B2 United States of America 09 Feb 2021
CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE Application US-20200281921-A1 United States of America 10 Sep 2020
Method of treating cancer associated with a RAS mutation Grant US-10668063-B2 United States of America 02 Jun 2020
Cancer treatment with combination of plinabulin and taxane Grant US-10596169-B2 United States of America 24 Mar 2020
Cancer treatment with combination of plinabulin and taxane Grant AU-2013402794-B2 Australia 27 Feb 2020
TREATMENT OF CANCER BY COMBINATION OF PLINABULIN AND TAXANE Application RU-2662298-C2 Russian Federation 25 Jul 2018
CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE Application WO-2015051543-A1 World Intellectual Property Organisation (WIPO) 16 Apr 2015